Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001567619-22-006234 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-01 | RVMD | Anders Jack | See Remarks | A - Grant | $0.00 | +11.6K | 20.0K | +138% | $0 |
| D | 2022-03-03 | 2022-03-01 | RVMD | Anders Jack | See Remarks | A - Grant | $0.00 | +40.6K | 40.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | A | A | 11,600 | $0.00 | 20,034 | D | — | — | (F1) Includes 17,613 Restricted Stock Units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-03-01 | A | A | 40,600 | $0.00 | 40,600 | D | $18.56 · — to 2032-02-29 | 40,600 Common Stock | (F2) One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2022 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date. |